CAROL JEAN ABESAMIS: Open Payments
NPI 1609088673 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 11 payments from 4 companies in 2025. Trend: 2023 $669 · 2024 $448 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $263 |
| AOP Health US, LLC | 1 | $257 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: Rapiblyk, Ozempic, FARXIGA, JARDIANCE, Wegovy.
Industry payments across NJ — which companies pay providers there.
